Dream Team aims to intercept pancreatic cancer before it flourishes
Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand Up to Cancer and led by an investigator at The University of Texas MD Anderson Cancer Center will test new ways to find the disease in its emerging, more vulnerable phase in people who are at high risk for developing it.
“Our plan is to intercept pancreatic cancer by finding it and stopping...
V. Craig Jordan, Ph.D., elected to the National Academy of Medicine
V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery of selective...
MD Anderson team selected for national push to expand immunotherapy
A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers...
MD Anderson expert to lead free Austin panel on Alzheimer’s disease
The University of Texas MD Anderson Cancer Center and Belmont Village Senior Living will present a free panel discussion in Austin exploring the scientific, social and emotional challenges of Alzheimer’s disease, 6:30-8 p.m., Wednesday, Oct. 25, at Belmont Village West Lake Hills, 4310 Bee Cave Rd. A free reception will begin at 6 p.m.
Jim Ray, Ph.D., head of Neuroscience Research, Institute for Applied Cancer Science at MD Anderson...
MD Anderson and BridgeBio Pharma launch Navire Pharma to develop targeted therapy for patients with difficult-to-treat cancer
The University of Texas MD Anderson Cancer Center and BridgeBio Pharma today announced the launch of Navire Pharma, a biopharmaceutical company...